Search - tctmd.com

Displaying 321 - 340 of 396

Sort: Relevancy | Date

Presentation TCT 2013

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Presenter: Juan Granada

October 28, 2013

Presentation TCT 2013

Translational Strategies for the Validation of RDN Therapies

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

The Amaranth PLLA-based BRS (with and without Sirolimus Elution): Design, Experimental and FIH Results

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

Metallic Stent Technology: Design Considerations

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

Coronary Artery Disease: Pathology and Pathogenesis

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

Can Experimental Data Inform This Debate?(2)

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

Can Experimental Data Inform This Debate?

Presenter: Juan Granada

October 27, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

Presentation SOLACI 2013

Mechanisms of Late Stent Failure: Late Catch Up and Neoatherosclerosis

Presenter: Juan F. Granada

July 25, 2013

Presentation SOLACI 2013

Drug-Coated Balloon Therapy for Peripheral Vascular Intervention

Presenter: Juan F. Granada

July 25, 2013

Presentation SOLACI 2013

When is a Device Ready for a FIH Study?

Presenter: Juan F. Granada

July 24, 2013

Presentation TCT Russia 2013

Basic Principles of Translational Research: When a Device is Ready for FIH Use

Presenter: Juan F. Granada

June 09, 2013

News Daily News

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Yael L. Maxwell

May 17, 2013

News Daily News

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Yael L. Maxwell

May 17, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Daily News

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

March 25, 2013

Presentation CIT 2013

Drug Delivery Mechanism and Vascular Healing

Presenter: Juan F. Granada

March 20, 2013

Presentation TCT 2013

Safety and Biocompatibility of the Coherex WaveCrest[sup]TM[/sup] Left Atrial Appendage Occluder in a 30-Day Canine Study

Presenter: Yanping Cheng, Jenn McGregor, Robert Sommer, William Gray, Daryl Edmiston, Gerard Conditt, Genghua Yi, Armando Tellez, Serge Rousselle, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Piotr Buszman, Yanping Cheng, Jong Shiuan Yeh, Gerard Conditt, Greg Kaluza, Juan Granada

January 31, 2013

Advertisement

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Translational Strategies for the Validation of RDN Therapies

The Amaranth PLLA-based BRS (with and without Sirolimus Elution): Design, Experimental and FIH Results

Metallic Stent Technology: Design Considerations

Coronary Artery Disease: Pathology and Pathogenesis

Can Experimental Data Inform This Debate?(2)

Can Experimental Data Inform This Debate?

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

Mechanisms of Late Stent Failure: Late Catch Up and Neoatherosclerosis

Drug-Coated Balloon Therapy for Peripheral Vascular Intervention

When is a Device Ready for a FIH Study?

Basic Principles of Translational Research: When a Device is Ready for FIH Use

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

Drug Delivery Mechanism and Vascular Healing

Safety and Biocompatibility of the Coherex WaveCrest[sup]TM[/sup] Left Atrial Appendage Occluder in a 30-Day Canine Study

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content